Skip to content

Staar Surgical STAA EBITDA margin

EBITDA margin at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
34.4%+2.7pp
Bausch Health Companies logo
Bausch Health CompaniesBHC
17%-11.8pp
IAR
Integra LifeSciencesIART
-19.5%-30.1pp
ITG
Integer HoldingsITGR
18.3%-0.8pp
Glaukos logo
GlaukosGKOS
-28.5%+57.9pp
HRO
HarrowHROW
8%+5.0pp

Other financials

Income statement

See full
Revenue$93.5M+120%
Gross profit$68.9M+146%
Operating income$8.0M+114%
Net income$5.2M+110%
EPS (diluted)$0.10+109%

Balance sheet

See full
Cash & equivalents$131.9M-23.8%
Total debt$37.3M+1.7%
Total equity$352.4M+0.7%
Total assets$451.1M-1.4%

Cash flow

See full
Operating cash flow-$21.7M-278%
CapEx$443.0K-69.8%
Free cash flow-$22.1M-207%

Valuation

See full
Market cap$1.44B+77.9%
Enterprise value$1.35B+100.0%
P/S+2.1×

Profitability

See full
Gross margin76.9%+2.9pp
Operating margin-9.1%-3.5pp
Net margin-7.2%-3.0pp
FCF margin-19.6%+55.9pp

Returns & leverage

See full
Return on equity-6%-2.4pp
Debt / equity0.1×0.0×
Current ratio5.1×+0.3×

Where this comes from

Calculated from Staar Surgical’s reported figures.

Based on trailing twelve months.

The official record: Staar Surgical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Staar Surgical's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Staar Surgical's EBITDA margin?
Staar Surgical (STAA) reported EBITDA margin of -6.3% in Q1 2026.
How has Staar Surgical's EBITDA margin changed year-over-year?
Staar Surgical's EBITDA margin increased by 70.6% year-over-year, from -21.4% to -6.3%.
What is the long-term trend for Staar Surgical's EBITDA margin?
Over 5 years (2020 to 2025), Staar Surgical's EBITDA margin has grown at a 42.0% compound annual growth rate (CAGR), from 6% to -34.8%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.